StonvexLoading…
StonvexStonvexStonvexCore line items from ORGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $477.00K | $18.92M | $15.90M | $11.24M |
Operating Income | $-16.51M | $-259.09M | $-64.52M | $-47.59M |
Net Income | $-17.65M | $-249.70M | $-55.57M | $-12.75M |
EPS (Diluted) | $-3.28 | $-50.55 | $-0.38 | $-0.27 |
Total Assets | $135.07M | $157.66M | $327.35M | $348.38M |
Total Liabilities | $46.76M | $53.45M | $32.36M | $37.25M |
Cash & Equivalents | $19.19M | $32.92M | $34.06M | $35.30M |
Free Cash Flow OCF − CapEx | $-11.84M | $-63.00M | $-44.97M | $-31.44M |
Shares Outstanding | 5.50M | 5.17M | 150.53M | 150.17M |